Biology of <i>Acinetobacter baumannii</i>: Pathogenesis, Antibiotic Resistance Mechanisms, and Prospective Treatment Options.
Lee CR, Lee JH, Park M, Park KS, Bae IK, Kim YB, Cha CJ, Jeong BC, Lee SH. · 2017
Read Biology of <i>Acinetobacter baumannii</i>: Pathogenesis, Antibiotic Resistance Mechanisms, and Prospective Treatment Options. by Lee CR, Lee JH, Park M, Park KS, Bae IK, Kim YB, Cha CJ, Jeong BC, Lee SH. (2017) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/europmc-pmc5346588.txt.
Introduction
Chang-Ro Lee and co-authors reviewed a hospital superbug in Frontiers in Cellular and Infection Microbiology in 2017. The germ, Acinetobacter baumannii, thrives in modern hospitals and preys on the very ill. Strains that shrug off most drugs now cause outbreaks in ward after ward, which leaves doctors with few working cures. The review sums up how it attacks and how it resists.
Its tools of attack span pore proteins in its coat, sugar shells, surface fats, fat-cutting enzymes, shed membrane bubbles, iron-grabbing systems, and protein pumps. Its drug shields are just as wide. It makes enzymes that break key drug classes, pumps drugs back out, alters drug targets, and seals its coat against entry. The authors close with fresh treatment ideas, from new drug hunts to pairing old drugs in smarter ways.
Catalog record
| CREATOR | Lee CR, Lee JH, Park M, Park KS, Bae IK, Kim YB, Cha CJ, Jeong BC, Lee SH. |
|---|---|
| YEAR | 2017 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 187 KB |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |